Anuh Pharma バランスシートの健全性
財務の健全性 基準チェック /66
Anuh Pharma has a total shareholder equity of ₹2.9B and total debt of ₹26.9M, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are ₹4.5B and ₹1.5B respectively. Anuh Pharma's EBIT is ₹636.0M making its interest coverage ratio -80. It has cash and short-term investments of ₹622.6M.
主要情報
0.9%
負債資本比率
₹26.93m
負債
| インタレスト・カバレッジ・レシオ | -80x |
| 現金 | ₹622.56m |
| エクイティ | ₹2.91b |
| 負債合計 | ₹1.54b |
| 総資産 | ₹4.46b |
財務の健全性に関する最新情報
更新なし
Recent updates
財務状況分析
短期負債: 506260's short term assets (₹3.4B) exceed its short term liabilities (₹1.5B).
長期負債: 506260's short term assets (₹3.4B) exceed its long term liabilities (₹17.7M).
デット・ツー・エクイティの歴史と分析
負債レベル: 506260 has more cash than its total debt.
負債の削減: 506260's debt to equity ratio has reduced from 2.7% to 0.9% over the past 5 years.
債務返済能力: 506260's debt is well covered by operating cash flow (480%).
インタレストカバレッジ: 506260 earns more interest than it pays, so coverage of interest payments is not a concern.